Burcuno

At Public Citizen's Global Access to Medicines Program, we have been monitoring the negotiations closely to see how the intellectual property proposal will affect access to medicines, innovation, research and development of pharmaceuticals. We have strong concerns that the proposal, if implemented, would restrict access to affordable medicines. This means that in TPP countries we will be paying higher prices for our medicines due to lengthened, strengthened and broadened pharmaceutical monopolies. For details please check http://bit.ly/RVHuCZ

Hey Micheal -- Derechos Digitales is one of our local partners in Chile. They are doing a great job there. Please check http://www.derechosdigitales.org/

The TPP grants a set of extreme foreign investor privileges and rights to multinational corporations through the notorious “investor-state” system. This system elevates individual corporations and investors to equal standing with each TPP signatory country's government.

Under this regime, foreign investors can skirt domestic courts and laws, and sue governments directly before tribunals of three private sector lawyers operating under World Bank and UN rules to demand taxpayer compensation for any domestic law that investors believe will diminish their "expected future profits." Over $675 million has been paid to foreign investors under U.S. trade pacts, while over $12 billion in claims are pending on environmental, safety, and public health policies under U.S. trade deals.

For more, please check Public Citizen's Global Trade Watch webpage on investor- state disputes http://www.citizen.org/Page.aspx?pid=5329

The TPP grants a set of extreme foreign investor privileges and rights to multinational corporations through the notorious “investor-state” system. This system elevates individual corporations and investors to equal standing with each TPP signatory country's government. Under this regime, foreign investors can skirt domestic courts and laws, and sue governments directly before tribunals of three private sector lawyers operating under World Bank and UN rules to demand taxpayer compensation for any domestic law that investors believe will diminish their "expected future profits." Over $675 million has been paid to foreign investors under U.S. trade pacts, while over $12 billion in claims are pending on environmental, safety, and public health policies under U.S. trade deals. For more, please check Public Citizen's Global Trade Watch webpage on investor- state disputes http://www.citizen.org/Page.aspx?pid=5329

There is a worrying trend to associate data exclusivity to data protection system introduced by the TRIPS Agreement, which protects undisclosed market registration data against disclosure and unfair commercial use. On the other hand, data exclusivity prevents FDA to rely on the originator’s data when registering a generic version of the same product & creates a de facto market exclusivity. The US IP proposal provides at least five years exclusivity for information (not only data) related to new products and three more in cases of new uses for old medicines - even that information is in the public domain.